Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shih-Tsung Huang
A Phase 3, Open-Label, Multicenter Study of a 6-Month Pre-Mixed Depot Formulation of Leuprolide Mesylate in Advanced Prostate Cancer Patients
World Journal of Urology
Urology
Related publications
Ceritinib Plus Nivolumab in Patients With Advanced ALK-rearranged Non-Small-Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Infliximab for Pediatric Patients With Ulcerative Colitis: A Phase 3, Open-Label, Uncontrolled, Multicenter Trial in Japan
BMC Pediatrics
Child Health
Pediatrics
Perinatology
A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder
Journal of Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
SAT0231 Safety of Subcutaneous Belimumab in Patients With Systemic Lupus Erythematosus: A 6-Month Open-Label Extension Study
A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
P1.01-32 a Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients With Interstitial Lung Disease
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase I Open Label Study of the Farnesyltransferase Inhibitor CP-609,754 in Patients With Advanced Malignant Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
The First-In-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
